Wordt geladen...
Current challenges for detection of circulating tumor cells and cell-free circulating nucleic acids, and their characterization in non-small cell lung carcinoma patients. What is the best blood substrate for personalized medicine?
The practice of “liquid biopsy” as a diagnostic, prognostic and theranostic tool in non-small cell lung cancer (NSCLC) patients is an appealing approach, at least in theory, since it is noninvasive and easily repeated. In particular, this approach allows patient monitoring during treatment, as well...
Bewaard in:
Gepubliceerd in: | Ann Transl Med |
---|---|
Hoofdauteurs: | , , , , , , , |
Formaat: | Artigo |
Taal: | Inglês |
Gepubliceerd in: |
AME Publishing Company
2014
|
Onderwerpen: | |
Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4245510/ https://ncbi.nlm.nih.gov/pubmed/25489581 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2305-5839.2014.08.11 |
Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|